STATE STREET CORP - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 101 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$312,152
-17.3%
30,306
+32.3%
0.00%
Q2 2023$377,491
-56.3%
22,906
-75.7%
0.00%
Q1 2023$864,695
-28.2%
94,399
-43.9%
0.00%
Q4 2022$1,204,498
+90.6%
168,226
+33.4%
0.00%
Q3 2022$632,000
+50.5%
126,135
-26.6%
0.00%
Q2 2022$420,000
-70.1%
171,952
-16.4%
0.00%
Q1 2022$1,406,000
-8.2%
205,794
+8.6%
0.00%
Q4 2021$1,531,000
-5.2%
189,516
+15.0%
0.00%
Q3 2021$1,615,000
+72.0%
164,784
+18.2%
0.00%
Q2 2021$939,000
-13.9%
139,464
+15.6%
0.00%
Q1 2021$1,091,000
+74.8%
120,693
+29.3%
0.00%
Q4 2020$624,000
+49.6%
93,316
+12.7%
0.00%
Q3 2020$417,000
+178.0%
82,798
+346.5%
0.00%
Q2 2020$150,000
-59.6%
18,542
-79.2%
0.00%
Q3 2019$371,000
+43.8%
89,1920.0%0.00%
Q2 2019$258,000
+101.6%
89,1920.0%0.00%
Q1 2019$128,000
-44.3%
89,1920.0%0.00%
Q4 2018$230,000
-41.3%
89,1920.0%0.00%
Q3 2018$392,000
-51.8%
89,192
-32.8%
0.00%
Q2 2018$813,000
-18.0%
132,662
-2.5%
0.00%
Q1 2018$992,000
+0.4%
136,110
+12.9%
0.00%
Q4 2017$988,000
+194.0%
120,537
+276.2%
0.00%
Q3 2017$336,000
-4.3%
32,043
+0.8%
0.00%
Q2 2017$351,000
+16.2%
31,782
+1.7%
0.00%
Q1 2017$302,000
-4.4%
31,259
+2.8%
0.00%
Q4 2016$316,00030,4010.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 985,210$10,345,0006.10%
Broadfin Capital, LLC 3,568,122$37,465,0005.54%
JW Asset Management, LLC 444,439$4,667,0003.42%
ARMISTICE CAPITAL, LLC 1,688,000$17,724,0002.09%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$38,383,0001.73%
FALCON POINT CAPITAL, LLC 661,490$6,284,0000.91%
KNOTT DAVID M 158,555$1,665,0000.71%
Perceptive Advisors 3,098,010$32,530,0000.62%
Sio Capital Management, LLC 91,413$960,0000.50%
HEARTLAND ADVISORS INC 700,000$7,350,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders